9-127829686-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001114753.3(ENG):c.360+1G>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001114753.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.360+1G>C | splice_donor_variant, intron_variant | Intron 3 of 14 | ENST00000373203.9 | NP_001108225.1 | ||
ENG | NM_000118.4 | c.360+1G>C | splice_donor_variant, intron_variant | Intron 3 of 13 | NP_000109.1 | |||
ENG | NM_001278138.2 | c.-187+1G>C | splice_donor_variant, intron_variant | Intron 3 of 14 | NP_001265067.1 | |||
ENG | NM_001406715.1 | c.360+1G>C | splice_donor_variant, intron_variant | Intron 3 of 7 | NP_001393644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.360+1G>C | splice_donor_variant, intron_variant | Intron 3 of 14 | 1 | NM_001114753.3 | ENSP00000362299.4 | |||
ENG | ENST00000344849.4 | c.360+1G>C | splice_donor_variant, intron_variant | Intron 3 of 13 | 1 | ENSP00000341917.3 | ||||
ENG | ENST00000480266.6 | c.-187+1G>C | splice_donor_variant, intron_variant | Intron 3 of 14 | 2 | ENSP00000479015.1 | ||||
ENG | ENST00000462196.1 | n.118+1G>C | splice_donor_variant, intron_variant | Intron 1 of 3 | 3 | ENSP00000519251.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The c.360+1G>C intronic pathogenic mutation results from a G to C substitution one nucleotide after coding exon 3 of the ENG gene. Alterations that disrupt the canonical splice site are expected to result in aberrant splicing. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. The resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNAdecay; however, direct evidence is unavailable. The exact functional effect of the altered amino acid sequence is unknown; however, the impacted region is critical for protein function and a significant portion of the protein is affected (Ambry internal data). This alteration was reported in a family with hereditary hemorrhagic telangiectasia (HHT), segregating in affected family members (Dakeishi M et al. Hum Mutat, 2002 Feb;19:140-8). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Hereditary hemorrhagic telangiectasia Pathogenic:1
Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 11793473). This sequence change affects a donor splice site in intron 3 of the ENG gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). Disruption of this splice site has been observed in individual(s) with hereditary hemorrhagic telangiectasia (HHT) (PMID: 11793473, 22991266, 12920067, 9366572). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.